Sources | Names Used |
---|---|
CTRPv2 | alisertib:navitoclax (2:1 mol/mol) |
PharmacoGx | alisertib:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | DKK1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | CACHD1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | PHF3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | NKX2-4 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
mRNA | SDK1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | BCL2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
mRNA | RAB9B | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | AC009336.19 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | GSK3B | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
mRNA | TTLL7 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |